The use of these agreements is not limited to pain clinics, but extends to anyone who prescribes controlled substances. A long-term study that describes the long-term use of opioid contracts for chronic pain treatment in primary care practice: a five-year experiment illustrates the broader needs of this type of conversation across particular types. Read and complete the full Controlled Substances Agreement (PDF) These contracts have grown in importance as regulatory oversight progresses and provide physicians with a documented way to inform patients of what they can expect if they are in their custody for pain treatment. They exist to help both the patient and the provider comply with the laws and regulations applicable to controlled substances. Opioids are frequently prescribed for chronic non-cancer pain (CNCP). Control Substance Agreements (SAAs) are intended to increase compliance and reduce the risk of opioid prescribing. We assessed the demographic characteristics and dosage of opioids for patients with CNCP admitted to SICs in a primary care practice. SACs have been proposed as emergency contracts, but their greatest strength may be to allow clinicians to take a population health management approach to treating patients with OPIOID CNCP. EHR registries that could draw clinicians` attention to opioid doses exceeding predefined thresholds, screening for drugs positive for illicit substances, and patients at high risk of opioid use disorder can have enormous potential to reduce risk for patients and providers and improve the overall management of opioid patients for CNCPs. What happens if a patient violates an agreement? Depending on the criteria set by the doctor or practice, a patient can be stripped of his controlled substances, or even released from the office. While this is a prerequisite for the prescription of controlled substances, consent requirements vary from state to state. Michigan, for example, will have a new law on June 1, 2018 with specific guidelines for a state-required form….